1Oppenheimer JH, Schwartz HL, Mariash CN,et al. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes[J]. J Clin Endocrinol Metab, 1982, 54:757-766.
2Mendel CM, Laughton CW, McMahon FA.Inability to detect an inhibitor of thyroxine -serum protein binding in sera from patients with nonthyroidal illness [ J ]. Metabolism,1991, d0:491-502.
3Berry M J, Larsen PR. The role of selenium in thyroid hormone action [ J ]. Endor Rev,1992. 13: 207-219.
4St Germain DL, Gahon VA. The deiodinase family of selenoproteins [ J ]. Thyroid,1997, 7:655-668.
5Berger MM, Lemarchand - Beraud T, Cavadini C, et al. Relations between the selenium status and the low T3 syndrome after major trauma [ J ]. Intensive Care Med, 1996, 22:575 -581.
6Bates JM, St Germain DL, Gahon VA. Expression profiles of the three iodothyronine deiodinases D1, D2 and D3, in the developing rat[J]. Endocrinology,1999,150:844 - 851.
7Peeters RP, Wouters PJ, Kaptein E, et al.Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients[J].J Clin Endocrinol Metab, 2003,88: 3202-3211.
8Schussler GC. The thyroxine -binding proteins[J]. Thyroid, 2000, 10: 141-149.
9Mclver B, Gorma CA. Euthyroid sick syndrome: an overview[ J ]. Thyroid, 1997,7: 125-132.
10Surks MI, Sievert R. Drugs and thyroid function[J]. N Engl J Med, 1995, 333:1688 - 1694.
